Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AGILENT TECHNOLOGIES, INC. | Director | Common Stock | 10.7K | $1.3M | $121.18 | Mar 14, 2025 | Direct |
INCYTE CORP | Director | Common Stock | 8.73K | $524K | $59.94 | Jun 12, 2024 | Direct |
Lyell Immunopharma, Inc. | Director | Common Stock | 35.6K | $20K | $0.56 | Mar 31, 2025 | Direct |
Lyell Immunopharma, Inc. | Director | Option (right to buy) | 130K | Jun 14, 2024 | Direct | ||
INCYTE CORP | Director | Non Qualfied Stock Option (right to buy) | 12.5K | Jun 12, 2024 | Direct | ||
INCYTE CORP | Director | Non-Qualified Stock Option (right to buy) | 11.3K | Jun 14, 2023 | Direct | ||
PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 9K | Jun 24, 2024 | Direct |